| Revenue growth | 20% YoY growth on proforma basis. |
|---|---|
| Margins | Improving; driven by operating leverage and better clinical case mix. |
| Demand visibility | Strong; 2 million patients treated in Q1, up 13% YoY. |
| Management confidence | High; citing historic milestone and strong shareholder support. |
Growth
Revenue rose 20% YoY to INR 2,597 Cr; EBITDA grew 30% to INR 576 Cr. EBITDA margin expanded 170 bps to 22.2%.
Outlook
Targeting 24-25% EBITDA margins in 2-3 years. Roadmap to add 4,170 beds, taking total capacity over 15,000.
Risks
One-time merger costs of INR 114 Cr; integration of large hospital networks; competitive intensity in metro markets like Bengaluru.
Last quarter's promises, checked
Delivered
- Guided merger completion within Q1 FY27 → delivered merger effective (BEAT)
- Targeted Whitefield Block D launch April 2026 → delivered 159-bed launch (BEAT)
- Guided 75-bed Ramesh Ongole launch April 2026 → delivered operationalization (BEAT)
Partly delivered
- Guided 2,500 bed addition over coming years → delivered 4,170 bed roadmap (PARTIAL - roadmap expanded)
Investor Presentation filed with BSE, NSE: ASTERDM. Summary written with AI assistance from the document.
Aster DM Quality Care Ltd: key numbers
- Share price
- ₹759.40
- Market cap
- ₹66,195 Cr
- Revenue (annual)
- ₹4,643 Cr
- Net profit (annual)
- ₹388.1 Cr
- P/E (TTM)
- 207.7×Sector 57.8×
- Promoter holding
- 53.72%+13.33% QoQ
- FII holding
- 10.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aster DM Quality Care Ltd
All →Aster DM Quality Care Annual General Meeting
Aster DM Quality Care issued an addendum to its 18th AGM notice, providing additional information regarding the proposed capital allocation framework for shareholders.
Aster DM Quality Care Credit Rating
ICRA upgraded KIMS Healthcare Management's long-term rating to AA (Stable) from AA-, removing it from Rating Watch. The upgrade reflects stronger parent support post-Aster-QCIL merger.
Aster DM Quality Care Share Pledge
Catalyst Trusteeship released a pledge and created a new hold on Aster DM Quality Care shares. The encumbrance secures term loan facilities from Barclays and JPMorgan.
Aster DM Quality Care Share Pledge
UMHL released a pledge and created a non-disposal undertaking over 2.49 Cr shares securing USD 210 million. The encumbrance backs UIPL's Barclays-JPMorgan loan facilities.
- Value
- ₹1,974 Cr
Aster DM Quality Care Capacity Expansion: ₹134.4 Cr Investment
Aster DM announced KIMSHEALTH New Block adding ~184 beds by May 2028 at a cost of ₹134.4 Crore. The expansion addresses space constraints in Trivandrum.
- Value
- ₹134.4 Cr
- Execution
- on or before May 2028
- hospital beds
- 184 beds
Aster DM Quality Care Annual Report
Aster DM Quality Care has submitted its Integrated Annual Report for FY 2025-26 and the notice for its 18th Annual General Meeting scheduled for September 28, 2026.